주의력결핍 과잉행동장애 한국형 치료 권고안 개정안(Ⅲ) = 약물치료

다국어 초록 (Multilingual Abstract)

The objective of this review is the revision of the Korean practice parameters for the pharmacological treatment of attention-deficit hyperactivity disorder (ADHD) based on the change in the diagnostic system from DSM-IV-TR to DSM-5 and psychopharmacological developments. For the evidence-based approach, the authors conducted a review of the literature, including controlled clinical trials, studies of the side effects of drugs, toxicology and meta-analyses from the United States and Europe, as well as recent research conducted in Korea. The review committee composed of Korean experts on ADHD reviewed the revised parameters. This revised version reveals how to use central nervous system psychostimulants, non-stimulants such as atomoxetine and alpha2 agonists, and other medication for ADHD, and how to manage the adverse effects of such medication. At the end of this revised version, the authors propose recommendations for the pharmacotherapy of ADHD.

목차 (Table of Contents)

• 서론
• 국내에서 사용 가능한 ADHD 약물
• 약물 부작용 및 고려 사항
• 특정 연령대에서의 약물치료
• 동반 질환이 있는 경우의 약물치료
• 치료순응도 및 장기치료
• 결론
• REFERENCES